Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

Allen S. Ho(Cedars-Sinai Medical Center), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), Ahmet Zehir(Natera (United States)), Nora Katabi(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Alan L. Ho(Memorial Sloan Kettering Cancer Center), Britta Weigelt(Memorial Sloan Kettering Cancer Center), Meagan Montesion(Boston Foundation), Lindsay Chan(Foundation Medicine (United States)), Martin G. Dalin(Sahlgrenska University Hospital), Nishant Agrawal(University of Chicago), Snjezana Doğan(Memorial Sloan Kettering Cancer Center), P. Andrew Futreal(Wellcome Sanger Institute), Patrick K. Ha(University of California, San Francisco), Angelica Ochoa(Memorial Sloan Kettering Cancer Center), Ian Ganly(Memorial Sloan Kettering Cancer Center), Adel K. El Naggar(The University of Texas MD Anderson Cancer Center), Jorge S. Reis‐Filho(AstraZeneca (France)), Timothy A. Chan(Cleveland Clinic), Justin Tepe, Jeffrey S. Ross(Unknown), David B. Solit(Memorial Sloan Kettering Cancer Center), Gowtham Jayakumaran(DNA Diagnostic (Denmark)), Vladimir Makarov(Memorial Sloan Kettering Cancer Center), Jie He(Foundation Medicine (United States)), Mark Bailey(Foundation Medicine (United States)), Vincent A. Miller(Universidad San Carlos), Petros Tsipouras
Journal of Clinical Investigation
September 3, 2019
Cited by 210


Related Papers